News
Solomon Center Fellow Spotlight: Hil Moss
Hil Moss is the Co-Founder and CEO of VivorCare, the first virtual survivorship clinic for cancer survivors.
Yale Insights
The Legal Determinants of Health
The Law and the End of the COVID-19 Public Health Emergency
In recent pieces, Professors Abbe R. Gluck and Cristina Rodríguez have discussed what comes next for health law and immigration policies as official pandemic-era emergency declarations have come to an end.
Lecture Explores How, For Vaccine Hesitant, Policies May Make Politics
Public policy scholar Katie Attwell discussed how California’s vaccine laws have shaped the politics of vaccination in the state in a lecture co-hosted by the Solomon Center.
Solomon Center Welcomes Regulatory Experts for a Panel on FDA Public Trust
The Solomon Center for Health Law and Policy hosted a panel on the public’s trust of the U.S. Food and Drug Administration and its decision-making process.
Alumni Advise Health Law and Policy Students
The Yale Health Law and Policy Society (YHeLPS), in collaboration with the Solomon Center for Health Law and Policy, hosted its annual career night on April 13. Panelists spoke to students on their career paths in health law, providing diverse perspectives on their fields and their roles. This year’s event featured six alumni panelists: Stephanie Akpa, Counselor at Office of Information and Regulatory Affairs (OIRA), Office of Management and Budget Paul Kalb, Partner, Sidley Austin LLP Allison Orris, Senior Fellow, Health Policy Center on Budget and Policy Priorities Adam Pan, Associate...
Panel Unpacks Supreme Court Case With Far-Reaching Implications For Medicaid and Beyond
Experts in Medicaid law discussed Supreme Court case Health and Hospital Corporation of Marion County v. Talevski, which could have far reaching impact for other federal programs.
Panel Examines Medication Abortion Access
The Solomon Center for Health Law and Policy hosted a panel discussion on issues related to medication abortion access and a recent challenge to the FDA’s approval of mifepristone.